|
MSL3L2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.08779999999464E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.782800E-03 |
| Normal-vs-Stage2 |
1.934990E-01 |
| Normal-vs-Stage3 |
7.845600E-04 |
| Normal-vs-Stage4 |
3.65450000000545E-05 |
| Stage1-vs-Stage2 |
5.229600E-01 |
| Stage1-vs-Stage3 |
1.601210E-01 |
| Stage1-vs-Stage4 |
3.483000E-03 |
| Stage2-vs-Stage3 |
9.395600E-02 |
| Stage2-vs-Stage4 |
2.160000E-03 |
| Stage3-vs-Stage4 |
5.398100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.49869999999763E-05 |
| Normal-vs-AfricanAmerican |
9.159900E-02 |
| Normal-vs-Asian |
1.329620E-01 |
| Caucasian-vs-AfricanAmerican |
8.442000E-01 |
| Caucasian-vs-Asian |
5.577400E-01 |
| AfricanAmerican-vs-Asian |
5.953800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85070000002785E-06 |
| Normal-vs-Female |
2.168300E-02 |
| Male-vs-Female |
4.793700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.480500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.824600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.5138699999917E-05 |
| Normal-vs-Age(81-100Yrs) |
4.339700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.223800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.912200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.616800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.436380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.238000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.373200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.970000E-02 |
| Normal-vs-Grade 2 |
7.022000E-03 |
| Normal-vs-Grade 3 |
6.27679999999353E-05 |
| Normal-vs-Grade 4 |
1.007620E-04 |
| Grade 1-vs-Grade 2 |
1.599990E-02 |
| Grade 1-vs-Grade 3 |
2.848600E-04 |
| Grade 1-vs-Grade 4 |
1.61309999999748E-05 |
| Grade 2-vs-Grade 3 |
9.733500E-02 |
| Grade 2-vs-Grade 4 |
5.098200E-03 |
| Grade 3-vs-Grade 4 |
4.222400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.178100E-03 |
| Normal-vs-ccB subtype |
3.144600E-03 |
| ccA subtype-vs-ccB subtype |
2.604000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.173800E-04 |
| Normal-vs-N1 |
5.661900E-02 |
| N0-vs-N1 |
4.085200E-01 |
|
|
